Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 166–180 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-6193 APOA2 Gene Familial Hypercholesterolemia Modifier Genetic Test This test evaluates the APOA2 gene for variants that modify the clinical severity of familial hypercholesterolemia.	Peripheral Whole Blood (EDTA tube)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["APOA2 gene variants", "Modifier alleles associated with FH severity"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication unless advised by a physician"] Indications ["Risk stratification in individuals with diagnosed FH", "Personalized lipid management planning", "Identifying individuals at higher risk for accelerated atherosclerosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-8 ICD-10: E78.01 Clinical summary This test evaluates the APOA2 gene for variants that modify the clinical severity of familial hypercholesterolemia.
TEST-3205 APOE Gene Analysis for Sea-Blue Histiocyte Disease (Genetic Test) This test evaluates the entire APOE gene for pathogenic mutations linked to Sea-Blue Histiocyte Disease.	Peripheral Whole Blood (FTA card or venous draw)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["APOE gene sequence", "Pathogenic mutations", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No fasting or special preparation is required."] Indications ["Suspected Sea-Blue Histiocyte Disease", "Family history of lipid storage disorders", "Need for genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 21605-8 ICD-10: E75.89 Clinical summary This test evaluates the entire APOE gene for pathogenic mutations linked to Sea-Blue Histiocyte Disease.
TEST-3704 APOE Gene Lipoprotein Glomerulopathy Genetic Test This genetic test identifies pathogenic variants in the APOE gene associated with lipoprotein glomerulopathy.	Whole Blood (EDTA), FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["APOE gene variants", "Pathogenic mutations"] Parameters [] Preparation ["Do not discontinue prescribed lipid-lowering, anticoagulant, or immunosuppressive medication prior to testing without explicit nephrologist approval."] Indications ["Biopsy-confirmed lipid thrombi in glomeruli", "Unexplained nephrotic syndrome with elevated apolipoprotein E levels", "Strong family history of early-onset kidney failure"] Measurement technique Confirm with laboratory Codes LOINC: 21673-1 ICD-10: E78.8 Clinical summary This genetic test identifies pathogenic variants in the APOE gene associated with lipoprotein glomerulopathy.
TEST-3772 APOE Genotyping (Alzheimer's Disease Type 2) Genetic Test This genetic test identifies the APOE genotype (ε2/ε3/ε4), assessing an individual's genetic predisposition to late-onset Alzheimer's disease.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["APOE ε2 allele", "APOE ε3 allele", "APOE ε4 allele"] Parameters [] Preparation ["Mandatory pre-test genetic counselling required"] Indications ["Assessment of genetic risk for late-onset Alzheimer's disease", "Personalized preventive planning based on genetic risk"] Measurement technique Confirm with laboratory Codes LOINC: 48818-7 ICD-10: Z13.858 Clinical summary This genetic test identifies the APOE genotype (ε2/ε3/ε4), assessing an individual's genetic predisposition to late-onset Alzheimer's disease.
TEST-3746 APP Gene Alzheimer Disease Type 1 Genetic Test This test detects pathogenic mutations in the APP gene associated with early-onset familial Alzheimer's disease.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the APP gene", "Amyloid precursor protein gene mutations"] Parameters [] Preparation ["No specific fasting required", "Inform physician of all medications"] Indications ["Assessment of early-onset familial Alzheimer's disease risk", "Diagnosis in individuals with suggestive clinical presentation and family history"] Measurement technique Confirm with laboratory Codes LOINC: 21645-4 ICD-10: G30.0 Clinical summary This test detects pathogenic mutations in the APP gene associated with early-onset familial Alzheimer's disease.
TEST-3979 APP Gene Cerebral Amyloid Angiopathy (CAA) Genetic Test This diagnostic test evaluates the entire APP gene for pathogenic variants associated with hereditary cerebral amyloid angiopathy (CAA) and familial Alzheimer's disease.	Peripheral Blood or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the APP gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number changes"] Parameters [] Preparation ["No fasting required", "Complete mandatory pre-test genetic counselling", "Provide a three-generation family history"] Indications ["Diagnosis of hereditary cerebral amyloid angiopathy (CAA)", "Diagnosis of familial Alzheimer’s disease", "Risk assessment for individuals with a family history of CAA or Alzheimer's disease"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: I68.0 Clinical summary This diagnostic test evaluates the entire APP gene for pathogenic variants associated with hereditary cerebral amyloid angiopathy (CAA) and familial Alzheimer's disease.
TEST-153 Aptamer Sequencing Data Analysis Test This test quantifies the concentrations of over 7,000 proteins circulating in the blood using aptamer-based multiplex proteomics and next-generation sequencing.	Peripheral whole blood (EDTA plasma)	4 Weeks	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Protein concentrations", "Molecular snapshot of physiological state"] Parameters [] Preparation ["No fasting required", "Avoid intense physical exertion 24 hours prior", "Inform the medical team of all dietary supplements and medications"] Indications ["Early detection of inflammatory conditions", "Early detection of oncologic conditions", "Early detection of metabolic conditions", "Proactive health assessment"] Measurement technique Confirm with laboratory Codes LOINC: 51953-5 ICD-10: Z13.89 Clinical summary This test quantifies the concentrations of over 7,000 proteins circulating in the blood using aptamer-based multiplex proteomics and next-generation sequencing.
TEST-3860 APTX Gene Ataxia-Oculomotor Apraxia Type 1 (AOA1) Genetic Test This genetic test evaluates the APTX gene for pathogenic variants associated with Ataxia-Oculomotor Apraxia Type 1 (AOA1). It identifies single-nucleotide variants, small insertion...	Whole Blood (Peripheral)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the APTX gene", "Single-nucleotide variants", "Small insertions and deletions", "Copy-number alterations"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9% — full gene coverage including intron-exon boundaries"}, {"name": "Methodology", "reference_range": "NGS with LC-MS/MS-validated library preparation"}, {"name": "Turnaround Time", "reference_range": "3 to 4 Weeks"}] Preparation ["No fasting required", "Pre-test genetic counselling session is mandatory"] Indications ["Individuals presenting with progressive cerebellar ataxia, oculomotor apraxia, and peripheral neuropathy", "Suspicion of Ataxia-Oculomotor Apraxia Type 1 (AOA1)"] Measurement technique Confirm with laboratory Codes LOINC: 82932-1 ICD-10: G11.3 Clinical summary This genetic test evaluates the APTX gene for pathogenic variants associated with Ataxia-Oculomotor Apraxia Type 1 (AOA1). It identifies single-nucleotide variants, small insertions/deletions, and copy-number variations.
TEST-3847 AQP2 Gene (Nephrogenic Diabetes Insipidus, Autosomal) Genetic Test This test identifies genetic mutations in the AQP2 gene associated with hereditary nephrogenic diabetes insipidus.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AQP2 gene", "Presence of mutations causing nephrogenic diabetes insipidus"] Parameters [] Preparation ["No specific fasting required", "Pre-test genetic counselling is mandatory"] Indications ["Suspected hereditary nephrogenic diabetes insipidus", "Congenital polyuria and polydipsia", "Family history of nephrogenic diabetes insipidus"] Measurement technique Confirm with laboratory Codes LOINC: 90219-3 ICD-10: N25.1 Clinical summary This test identifies genetic mutations in the AQP2 gene associated with hereditary nephrogenic diabetes insipidus.
TEST-3968 AR Gene (Androgen Receptor) Genetic Test This genetic test analyzes the entire androgen receptor (AR) gene to detect pathogenic variants linked to PAIS and breast cancer risk.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AR gene", "Androgen receptor coding region analysis"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications being taken"] Indications ["Diagnosis of partial androgen insensitivity syndrome (PAIS)", "Assessment of hereditary breast cancer risk", "Evaluation of ambiguous genitalia", "Investigation of delayed puberty"] Measurement technique Confirm with laboratory Codes LOINC: 96978-0 ICD-10: E34.5, Z15.01 Clinical summary This genetic test analyzes the entire androgen receptor (AR) gene to detect pathogenic variants linked to PAIS and breast cancer risk.
TEST-5820 AR Gene Spinal & Bulbar Muscular Atrophy (SBMA) Genetic Test This genetic test evaluates the androgen receptor (AR) gene for CAG trinucleotide repeat expansions, which are the cause of Spinal and Bulbar Muscular Atrophy (SBMA).	Peripheral Whole Blood or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansions in the AR gene", "Presence of pathogenic variants in the AR gene"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counseling session recommended"] Indications ["Suspected diagnosis of Spinal and Bulbar Muscular Atrophy (SBMA)", "Family history of SBMA", "Differential diagnosis of motor neuron disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G12.2 Clinical summary This genetic test evaluates the androgen receptor (AR) gene for CAG trinucleotide repeat expansions, which are the cause of Spinal and Bulbar Muscular Atrophy (SBMA).
TEST-5547 ARFGEF2 Gene Periventricular Heterotopia with Microcephaly Genetic Test This test identifies pathogenic variants in the ARFGEF2 gene associated with periventricular nodular heterotopia and microcephaly.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARFGEF2 gene coding region variants", "Pathogenic mutations, small indels, copy number variants"] Parameters [] Preparation ["Detailed neurological and developmental history of the patient.", "Mandatory pre-test genetic counselling session."] Indications ["Suspected periventricular nodular heterotopia", "Suspected microcephaly with neurological symptoms", "Family history of ARFGEF2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 73732-6 ICD-10: Q04.8, Q02 Clinical summary This test identifies pathogenic variants in the ARFGEF2 gene associated with periventricular nodular heterotopia and microcephaly.
TEST-5487 ARHGAP31 Gene Adams-Oliver Syndrome Type 1 Genetic Test This test evaluates the ARHGAP31 gene for mutations associated with Adams-Oliver syndrome type 1.	Peripheral Whole Blood or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARHGAP31 gene sequence", "Point mutations", "Small insertions/deletions", "Copy number variants"] Parameters [] Preparation [] Indications ["Suspected Adams-Oliver syndrome type 1", "Confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 82371-6 ICD-10: Q87.2 Clinical summary This test evaluates the ARHGAP31 gene for mutations associated with Adams-Oliver syndrome type 1.
TEST-3629 ARHGDIA Gene Nephrotic Syndrome Type 8 Genetic Test This test identifies pathogenic variants in the ARHGDIA gene associated with autosomal recessive nephrotic syndrome type 8 (SRNS8).	Whole Blood (EDTA) or Buccal Swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARHGDIA gene", "Single-nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation [] Indications ["Diagnosis of steroid-resistant nephrotic syndrome type 8 (SRNS8)", "Family history of SRNS8", "Guiding therapeutic management", "Cascade screening in at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 81413-4 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the ARHGDIA gene associated with autosomal recessive nephrotic syndrome type 8 (SRNS8).
TEST-5693 ARHGEF10 Gene Slowed Nerve Conduction Velocity, Autosomal Dominant Genetic Test This test identifies pathogenic variants in the ARHGEF10 gene, which are responsible for autosomal dominant slowed nerve conduction velocity neuropathy.	Peripheral whole blood (5 mL EDTA), extracted DNA, or dried blood spot on FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARHGEF10 gene sequence", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Diagnosis of autosomal dominant inherited neuropathy with slowed nerve conduction velocity", "Family risk assessment for CMT2", "Confirmation of clinical suspicion based on nerve conduction studies"] Measurement technique Confirm with laboratory Codes LOINC: 51966-3 ICD-10: G60.0 Clinical summary This test identifies pathogenic variants in the ARHGEF10 gene, which are responsible for autosomal dominant slowed nerve conduction velocity neuropathy.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories